TLANDO, a Novel Oral TRT, Improves Sexual and Mental Domain Outcomes in Hypogonadal Men (original) (raw)
Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety
B. Woun Seo
The Journal of Sexual Medicine
View PDFchevron_right
The Promise and Challenges of Oral Testosterone Therapy. Journal Article
Julian Borges MD
MedNEXT Journal of Medical and Health Sciences, 5(4)., 2024
View PDFchevron_right
Oral Testosterone Therapy in Hypogonadal Men: A Comprehensive Systematic Review and Meta-Analysis of Safety, Efficacy, and Secondary Health Outcomes
Julian Borges MD
. Journal S Endocrinology Diab Met JSEDM. ISSN: 2768-413X , 2024
View PDFchevron_right
Evidence-based Medicine Update on Testosterone Replacement Therapy (TRT) in Male Hypogonadism: Focus on New Formulations
Vincenzo Triggiani, Vito Giagulli
Current Pharmaceutical Design, 2011
View PDFchevron_right
Clinical Efficacy of the Long-Acting Intramuscular Compared to Oral Testosterone Undecanoate in Adult Men with Central Hypogonadism
Monica Gheorghiu
Acta Endocrinologica (Bucharest), 2008
View PDFchevron_right
Intramuscular Testosterone Undecanoate: Pharmacokinetic Aspects of a Novel Testosterone Formulation during Long-Term Treatment of Men with Hypogonadism
alaa hagag
Journal of Clinical …, 2004
View PDFchevron_right
Reexamination of Pharmacokinetics of Oral Testosterone Undecanoate in Hypogonadal Men With a New Self-Emulsifying Formulation
Ronald Swerdloff
Journal of Andrology, 2012
View PDFchevron_right
Pharmacokinetics and Safety of Long-Acting Testosterone Undecanoate Injections in Hypogonadal Men: An 84-Week Phase III Clinical Trial
Ronald Swerdloff
2010
View PDFchevron_right
Pharmacokinetics, Efficacy, and Safety of a Permeation-Enhanced Testosterone Transdermal System in Comparison with Bi-Weekly Injections of Testosterone Enanthate for the Treatment of Hypogonadal Men 1
Norman Mazer
The Journal of Clinical Endocrinology & Metabolism, 1999
View PDFchevron_right
Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome
L. Gooren
Andrologia, 2008
View PDFchevron_right
Testosterone treatment longer than 1 year shows more effects on functional hypogonadism and related metabolic, vascular, diabetic and obesity parameters (results of the 2-year clinical trial)
Ivan Zuran
The Aging Male, 2020
View PDFchevron_right
Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions
Juliana Chan
Mayo Clinic proceedings, 2016
View PDFchevron_right
Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men
S. Freude
European Journal of Endocrinology, 2009
View PDFchevron_right
Testosterone replacement therapy: current trends and future directions
E. Nieschlag, J. Corrales
Human Reproduction Update, 2004
View PDFchevron_right
The benefits and risks of testosterone replacement therapy: a review
Nazem Bassil
Therapeutics and Clinical Risk Management, 2009
View PDFchevron_right
Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome
Antonio Aversa
2010
View PDFchevron_right
Androgen Replacement with Oral Testosterone Undecanoate in Hypogonadal Men: A Double Blind Controlled Study
P. Warner
Clinical Endocrinology, 1981
View PDFchevron_right
Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
julian barth
Clinical Endocrinology, 2021
View PDFchevron_right
Effect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trial
Khoo Ee Ming
Asian Journal of Andrology, 2012
View PDFchevron_right
Testosterone therapy for functional hypogonadism in middle-aged and elderly males: current evidence and future perspectives
Georgios Feretzakis, Nikolaos Theodorakis
Hormones, 2024
View PDFchevron_right
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline
Frances Hayes
The Journal of clinical endocrinology and metabolism, 2018
View PDFchevron_right
The Aging Male Important lessons about testosterone therapy - weight loss vs. testosterone therapy for symptom resolution, classical vs. functional hypogonadism, and shortterm vs. lifelong testosterone therapy
Monica Caliber
Aging Male. 2019 Jan 16:1-7
View PDFchevron_right
Androgen therapy of hypogonadal men with transscrotal testosterone systems
David Garza
The American Journal of Medicine, 1987
View PDFchevron_right
Myths and Controversies in Hypogonadism Treatment of Aging Males
cristina preda
Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi
View PDFchevron_right
The Current Status of Therapy for Symptomatic Late-Onset Hypogonadism with Transdermal Testosterone Gel
Ridwan Shabsigh
European Urology, 2005
View PDFchevron_right
Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men
Norman Mazer
Clinical Endocrinology, 1997
View PDFchevron_right